Ingrezza 40 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5Q20
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,748
Award facts
- Contract value 100% obligated
- $7,748.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,748.14 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count package) on November 28, 2025, with completion scheduled for December 19, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
Ingrezza (valbenazine) is an FDA-approved medication for treating tardive dyskinesia, a movement disorder that can result from prolonged antipsychotic medication use, making it a critical therapeutic option within the military's medical supply chain. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive portfolio of federal medical contracts with DLA and the Defense Health Agency, supplying branded and generic medications across multiple therapeutic domains to support military and veteran healthcare systems. This contract award demonstrates the company's ongoing role as a critical vendor for specialized pharmaceutical products supporting federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26F5Q20?
SPE2DR26F5Q20 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26F5Q20 worth?
The government has obligated $7,748 on SPE2DR26F5Q20.
Is contract SPE2DR26F5Q20 an order under another contract?
Yes. SPE2DR26F5Q20 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Q20 competed?
The extent of competition for SPE2DR26F5Q20 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award